Previous STEP Seminar Series

STEP invites local and international colleagues to present their research and ideas on the general themes of health screening, monitoring and diagnostic testing. Speakers vary from academic researchers to public policy makers and are invariably topical and informative.

2013

Date Speaker Topic Venue

Wednesday        15 February 

Armando Teixeira-Pinto 

School of Public Health
University of Sydney

Predisposition, Insult/Infection, Response and Organ desfunction (PIRO): from a theoretical concept to a clinical staging system for hospital mortality in patients with infrction.

Audio

Chemistry Lecture Theatre 2

Monday
4 March            

Jim Dickinson 

University of Calgary

When should we start and stop cervical screening? Evidence from Canada. Chemistry Lecture Theatre 4
Wednesday               20 March Mariska Leeflang 

Academic Medical Center, Amsterdam

Interpretation of the results of diagnostic test accuracy meta-analyses. Chemistry Lecture Theatre 1
Wednesday                17 April Lucie Rychetnik 

School of Public Health,
University of Sydney

Post-treatment follow-up and monitoring of patients with stagei/ii melanoma: a study of melanoma clinicians' perspectives.

Chemistry Lecture Theatre 1
Wednesday              15 May Clement Loy 

School of Public Health,

University of Sydney

Clinical diagnosis of Huntington Disease: a critical rethink Chemistry Lecture Theatre 1
Monday 
27 May
Julien Mancini 

Aix-Marseille University and Timone Hospital

Participation in biomedical research: French cancer patients' views and experiences. Norman Gregg Lecture Theatre
Wednesday              19 June Jenny Doust 

Centre for Research in Evidence Based Practice,
Bond
University                    

Preventing overdiagnosis: How to stop harming the healthy.

Presentation slides

Audio

Chemistry Lecture Theatre 1
Monday                  
24 June

John Witte

University of California 

The value of genomic information for disease risk prediction and screening.

Audio

Chemistry Lecture Theatre 2

Wednesday              17 July 

Cancelled  

Chemistry Lecture Theatre 1

Monday             
12 August
6pm
Assoc. Prof Nehmat Houssami
Screening and Test Evaluation Program,
School of Public Health,
University of Sydney
Digital Breast Tomosynthesis for population Brest Screening - results of the STORM trial Kerry Packer Education
Centre,
Royal Prince Alfred Hospital
Wednesday              18 September Robin Turner
School of Public Health,
University of Sydney
Understanding the effect of patient choice: designing a randomised trial to estimate treatment, selection and preference (choice) effects. Chemistry Lecture Theatre 1
Wednesday              16 October Carissa Bonner & Jesse Jansen
School of Public Health,
University of Sydney
The Healthy Heart Study Chemistry Lecture Theatre 1
Wednesday              20 November

Gemma Jacklyn, Kristen Pickles & Jane Williams
Centre for Values, Ethiocs & Law in Medicine,
School of Public Health,
University of Sydney 

Cancer screening in practice Chemistry Lecture Theatre 1

2012

Date Speaker Topic Venue
15 February Tom Lung

School of Public Health,
University of Sydney
Cost-effectiveness of monitorring renal function for patients with type 1 and type 2 diabetes in the United Kingdom. Chemistry
Lecture
Theatre 4
23 February Sverre Sandberg

Adjunct Professor
Department of
Public Health &
Primary Health Care,
University of Bergen,
Norway
Do clinicians use the concepts of biological variation and reference change values (critical differences) when monitoring patients with laboratory tests? Chemistry
Lecture
Theatre 4
29 February James Hanley

Professor
Department of Epidemiology &
Biostatistics
McGill University,
Canada
How big are the mortality reductions produced by cancer screening? Why do so many trials report only 20%? Chemistry
Lecture
Theatre 4
21 March Prof Bruce Armstrong

Professor of Public Health,
School of Pulic Health,
University of Sydney
Where we are now with prostate cancer screening? Chemistry
Lecture
Theatre 4
4 April Dr Patrick Bossuyt

Univsity of Amstredam,
Netherlands
Casual claims in clinical and public health research. Chemistry
Lecture
Theatre 4
16 May Dr Andrew Hayen & Dr Katy Bell

School of Public Health,
University of Sydney
Monitoring absolute cardiovascular risk: how often do we need to re-measure? Chemistry
Lecture
Theatre 4
20 June Dr Magid A Fahim

Department of Nephrology,
Princess Alexandra
Hospital
The power and pitfalls of change - making sense of serial test results. Chemistry
Lecture
Theatre 4
15 August Shannon McKinn

School of Public Health,
University of Sydney

Jolyn Hersch

School of Public Health,
University of Sydney
Communication in Cardiovascular Disease Risk Assessment and Management: the Influence of Psychosocial Factors.





Overdiagnosis in Breast Screenng: What do Women Think?
Chemistry
Lecture
Theatre 4
19 September Prof Michael Barry

Professor of Medicine,
Harvard Medical School,
President,
Informed Medical Decisions Foundation
Prostate Cancer Intervension versus Observation Trial (PIVOT): What are the Implications for Screening? Chemistry
Lecture
Theatre 4
17 October Dr Germaine Wong

School of Public Health,
University of Sydney
Detect Study. Chemistry
Lecture
Theatre 4
21 November Dr Gabrielle Williams,
Dr Sukanya De &
Tom Lung

Children's Hospital
Westmead
Further results from the FEVER study. Chemistry
Lecture
Theatre 4

2011

Date Speaker Topic
16 February Dr Christopher Jordens

Research Fellow & Senior Lecturer
Centre for Values, Ethics & the Law in Medicine
University of Sydney

Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer
16 March Tracy Merlin

Senior Lecturer
Discipline of Public Health
University of Adelaide

Feasibility of the Linked Evidence Approach (LEA) when assessing diagnostic tests for public funding
20 April Philip Clark

School of Public Health
University of Sydney

Funding Grant Proposals for Scientific Research
4 May Prof Jack Dowie

School of Public Health
University of Sydney

Supporting, documenting and evaluating the patient-centred decision using an online program: My Decision Suite
17 May Combined HEC & STEP talk 

Dr Karen Canfell

Senior Research Fellow
Cancer Epidemiology Research Unit
Cancer Council NSW

Challenges in evaluating new strategies for cervical cancer prevention: Integrating Cervical Screening and HPV Vaccination
15 June Nic Lucas

School of Public Health
University of Sydney

Development of a quality appraisal tool for studies of diagnostic reliability
20 July Rachael Morton

School of Public Health
University of Sydney

Patient Preferences for the Treatment of Chronic Kidney Disease
16 August 1. Dr Meagan Brennan

Clinical Senior Lecturer
School of Public Health
University of Sydney

2. Luke Marinovich

PhD Candidate
School of Public Health
University of Sydney

1. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI



2. Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Factors Associated with Invasive Breast Cancer at Excision Histology
29 September Prof Patrick Brennan

Professor of Diagnostic Radiography
Discipline of Medical Radiation Sciences
University of Sydney

Medical Image Perception and Optimisation
16 November David Peiris

Senior Research Fellow
Renal & Metabolic Division
The George Institute for Global Health

Health Tracker - A novel decision support system for primary health care

 

2008

Date Speaker Topic
20 February Lyndal Trevana FOBT Decision Analysis for bowel cancer screening
19 March Stephen Colagiuri Screening for Diabetes
16 April Angela Webster & Germaine Wong Cancer Screening and cancer risk, and mortality in people with kidney disease
21 May Steve Morell Is there a difference in high-grade cervical abnormalities by 2- or 3-year screening interval?
16 July Sally Lord & Les Irwig Test evaluation: Using test accuracy and other intermediate outcomes as an alternative for RCTs
3 September Stephen Walter Estimating threshold patient risks to justify clinical interventions

17 September

Les Irwig, Katy Bell & Andrew Hayen Should we monitor blood pressure after treatment is started?
29 October Stefano Ciatto  -
19 November Barbara-Ann Adelstein & Les Irwig Systematic Review of screening for colorectal cancer and CRISP



For further information or to be placed on a mailing list, please contact